SCIENTURE HOLDINGS, INC. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
SCIENTURE HOLDINGS, INC. (SCNX) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $144.56 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2026-03-30
- SCIENTURE HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-09-30 was $144.56K, a 32981.24% increase year-over-year.
- SCIENTURE HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-06-30 was $162.44K, a 36485.14% increase year-over-year.
- SCIENTURE HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-03-31 was $437.00, a 98.20% decline year-over-year.
- SCIENTURE HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2024-09-30 was $437.00, a 88.38% decline year-over-year.
- SCIENTURE HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2024 was $25.58K, a 13.97% decline from fiscal 2023.
- SCIENTURE HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2023 was $29.74K, a 62.43% decline from fiscal 2022.
- SCIENTURE HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $79.16K, a 57.73% decline from fiscal 2021.
- SCIENTURE HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2021 was $187.27K, a 58.24% decline from fiscal 2020.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2025-09-30 | $144.56K 10-Q · filed 2025-11-12 | $307.00K derived: sum of 2 quarters · filed 2025-11-12 | $307.44K derived: sum of 3 quarters · filed 2025-11-12 | |
| 2025-06-30 | $162.44K 10-Q · filed 2025-11-12 | $162.88K derived: sum of 2 quarters · filed 2025-11-12 | ||
| 2025-03-31 | $437.00 10-Q · filed 2025-11-12 | |||
| 2024-12-31 | $25.58K 10-K · filed 2026-03-30 | |||
| 2024-09-30 | $437.00 10-Q · filed 2025-11-12 | $881.00 derived: sum of 2 quarters · filed 2025-11-12 | $25.15K derived: sum of 3 quarters · filed 2025-11-12 | |
| 2024-06-30 | $444.00 10-Q · filed 2025-11-12 | $24.71K derived: sum of 2 quarters · filed 2025-11-12 | ||
| 2024-03-31 | $24.27K 10-Q · filed 2025-11-12 | |||
| 2023-12-31 | $29.74K 10-K · filed 2025-03-26 | |||
| 2023-09-30 | $3.76K 10-Q · filed 2024-11-06 | $11.54K derived: sum of 2 quarters · filed 2024-11-06 | $25.98K derived: sum of 3 quarters · filed 2024-11-06 | |
| 2023-06-30 | $7.78K 10-Q · filed 2024-11-06 | $22.22K derived: sum of 2 quarters · filed 2024-11-06 | ||
| 2023-03-31 | $14.43K 10-Q · filed 2024-11-06 | |||
| 2022-12-31 | $79.16K 10-K · filed 2024-04-22 | |||
| 2022-09-30 | $17.66K 10-Q · filed 2024-01-16 | $34.66K derived: sum of 2 quarters · filed 2024-01-16 | $67.44K derived: sum of 3 quarters · filed 2024-01-16 | |
| 2022-06-30 | $16.99K 10-Q · filed 2024-01-16 | $49.78K derived: sum of 2 quarters · filed 2024-01-16 | ||
| 2022-03-31 | $32.78K 10-Q · filed 2024-01-16 | |||
| 2021-12-31 | $187.27K 10-K · filed 2023-03-27 | |||
| 2021-09-30 | $54.17K 10-Q · filed 2022-11-07 | $115.57K derived: sum of 2 quarters · filed 2022-11-07 | $191.31K derived: sum of 3 quarters · filed 2022-11-07 | |
| 2021-06-30 | $61.39K 10-Q · filed 2022-11-07 | $137.13K derived: sum of 2 quarters · filed 2022-11-07 | ||
| 2021-03-31 | $75.74K 10-Q · filed 2022-11-07 | |||
| 2020-12-31 | $448.40K 10-K · filed 2022-03-28 | |||
| 2020-09-30 | $127.00K 10-Q · filed 2021-10-25 | $310.90K derived: sum of 2 quarters · filed 2021-10-25 | $372.90K derived: sum of 3 quarters · filed 2021-10-25 | |
| 2020-06-30 | $183.91K 10-Q · filed 2021-10-25 | $245.90K derived: sum of 2 quarters · filed 2021-10-25 | ||
| 2020-03-31 | $62.00K 10-Q · filed 2021-10-25 | |||
| 2019-12-31 | $176.38K 10-K · filed 2021-03-29 | |||
| 2019-09-30 | $41.60K 10-Q · filed 2020-10-26 | $105.61K derived: sum of 2 quarters · filed 2020-10-26 | $141.59K derived: sum of 3 quarters · filed 2020-10-26 | |
| 2019-06-30 | $64.01K 10-Q · filed 2020-10-26 | $99.99K derived: sum of 2 quarters · filed 2020-10-26 | ||
| 2019-03-31 | $35.98K 10-Q · filed 2020-10-26 | |||
| 2018-12-31 | $169.83K 10-K · filed 2020-03-30 | |||
| 2018-09-30 | $44.98K 10-Q · filed 2019-10-28 | $95.59K derived: sum of 2 quarters · filed 2019-10-28 | $133.05K derived: sum of 3 quarters · filed 2019-10-28 | |
| 2018-06-30 | $50.62K 10-Q · filed 2019-10-28 | $88.07K derived: sum of 2 quarters · filed 2019-10-28 | ||
| 2018-03-31 | $37.46K 10-Q · filed 2019-10-28 | |||
| 2017-12-31 | $267.83K 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |